Symptoms of prostate cancer prostate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Prostate Cell Line, Tumor Tumor Cells, Cultured Epithelial Cells Seminal Vesicles Chromosomes, Human, Pair 8 Neoplastic Stem Cells Rectum Stromal Cells Neoplastic Cells, Circulating Cell Nucleus

Organisms5

Mice, Nude Mice, SCID Mice, Transgenic Mice, Inbred BALB C Mice, Inbred C57BL

Diseases33

Prostatic Neoplasms Prostatic Hyperplasia Neoplasms, Hormone-Dependent Prostatic Intraepithelial Neoplasia Adenocarcinoma Disease Progression Neoplasm Metastasis Bone Neoplasms Neoplasm Invasiveness Genetic Predisposition to Disease Neoplasms Breast Neoplasms Prostatic Diseases Carcinoma Prostatic Neoplasms, Castration-Resistant Neoplasm Recurrence, Local Prostatitis Lung Neoplasms Ovarian Neoplasms Colonic Neoplasms Cell Transformation, Neoplastic Stomach Neoplasms Neovascularization, Pathologic Disease Models, Animal Pancreatic Neoplasms Urinary Bladder Neoplasms Colorectal Neoplasms Erectile Dysfunction Urination Disorders Neoplastic Cells, Circulating Uterine Cervical Neoplasms Fatigue Radiation Injuries

Chemicals and Drugs70

Prostate-Specific Antigen Receptors, Androgen Androgens Androgen Antagonists Tumor Markers, Biological Tosyl Compounds Androgen Receptor Antagonists Antineoplastic Agents, Hormonal Antineoplastic Agents Dihydrotestosterone Anilides Finasteride Neoplasm Proteins RNA, Messenger Metribolone Flutamide 5-alpha Reductase Inhibitors Glutamate Carboxypeptidase II Anticarcinogenic Agents RNA, Small Interfering Taxoids PTEN Phosphohydrolase Testosterone Testosterone Congeners Cancer Vaccines Azasteroids DNA, Neoplasm 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Androstenols Antigens, Neoplasm Cholestenone 5 alpha-Reductase Phenylthiohydantoin Antineoplastic Agents, Phytogenic Nitriles Racemases and Epimerases Proto-Oncogene Proteins c-akt Estramustine Leuprolide Transcription Factors RNA, Neoplasm Goserelin Androgen-Binding Protein Glutathione S-Transferase pi Prostatic Secretory Proteins Tumor Suppressor Protein p53 Tumor Suppressor Proteins MicroRNAs Kallikreins DNA-Binding Proteins Enzyme Inhibitors Steroid 17-alpha-Hydroxylase Receptor, erbB-2 DNA Primers Antibodies, Monoclonal Oncogene Proteins, Fusion Proto-Oncogene Proteins c-bcl-2 Proto-Oncogene Proteins Insulin-Like Growth Factor Binding Protein 3 Receptors, Estrogen Carotenoids Trans-Activators Paclitaxel Plant Extracts Ki-67 Antigen Selenium Androstane-3,17-diol Diphosphonates Gonadotropin-Releasing Hormone Cadherins Nuclear Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment81

Prostatectomy Orchiectomy Early Detection of Cancer Neoplasm Grading Transurethral Resection of Prostate Neoplasm Staging Risk Factors Digital Rectal Examination Prognosis Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Case-Control Studies Immunohistochemistry Neoplasm Transplantation Prospective Studies Follow-Up Studies Transplantation, Heterologous Treatment Outcome Biopsy Blotting, Western Retrospective Studies Gene Expression Profiling Sensitivity and Specificity Risk Biopsy, Needle Brachytherapy Risk Assessment Cohort Studies Questionnaires Incidence Survival Rate Survival Analysis Castration Odds Ratio Predictive Value of Tests Transfection Tumor Burden Oligonucleotide Array Sequence Analysis Combined Modality Therapy Multivariate Analysis Tissue Array Analysis Reproducibility of Results Logistic Models Disease-Free Survival Radiotherapy, Conformal Radiotherapy SEER Program Radiotherapy Dosage Polymerase Chain Reaction Nomograms Registries Mass Screening Antineoplastic Combined Chemotherapy Protocols Kaplan-Meier Estimate Molecular Targeted Therapy Drug Screening Assays, Antitumor Disease Models, Animal Confidence Intervals Models, Biological Radiotherapy, Intensity-Modulated Clinical Trials as Topic Radiotherapy Planning, Computer-Assisted Immunoenzyme Techniques Gene Knockdown Techniques Flow Cytometry In Situ Hybridization, Fluorescence Proportional Hazards Models ROC Curve Radiotherapy, Image-Guided Image-Guided Biopsy Magnetic Resonance Imaging Tomography, X-Ray Computed Prevalence Symptom Assessment Regression Analysis Real-Time Polymerase Chain Reaction Immunotherapy Genetic Therapy Severity of Illness Index Drug Administration Schedule Immunoblotting

Psychiatry and Psychology3

Erectile Dysfunction Depression Smoking

Phenomena and Processes44

Gene Expression Regulation, Neoplastic Cell Proliferation Apoptosis Genetic Predisposition to Disease Signal Transduction Sensitivity and Specificity Risk Cell Growth Processes Time Factors Down-Regulation Cell Division Genotype Drug Resistance, Neoplasm Cell Survival Odds Ratio Transfection Cell Movement Up-Regulation DNA Methylation Promoter Regions, Genetic Dose-Response Relationship, Drug Cell Cycle Polymorphism, Genetic Nomograms Gene Fusion Mutation Chromosomes, Human, Pair 8 Gene Silencing Genes, Tumor Suppressor RNA Interference Base Sequence Gene Expression Polymorphism, Single Nucleotide Phosphorylation Diet Alleles Transcription, Genetic Phenotype Genes, Neoplasm Drug Synergism Germ-Line Mutation Oncogene Fusion Radiation Tolerance Transcriptional Activation

Disciplines and Occupations3

Immunohistochemistry Urology Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science11

Questionnaires Incidence Survival Rate Radiotherapy, Conformal SEER Program Registries Base Sequence Molecular Sequence Data Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Prevalence

Named Groups4

European Continental Ancestry Group African Americans Survivors African Continental Ancestry Group

Health Care36

Risk Factors Watchful Waiting Case-Control Studies Prospective Studies Follow-Up Studies Treatment Outcome Retrospective Studies Sensitivity and Specificity Risk Risk Assessment Cohort Studies Questionnaires Incidence Survival Rate Survival Analysis Odds Ratio Age Factors Predictive Value of Tests Multivariate Analysis Reproducibility of Results Logistic Models Disease-Free Survival SEER Program Nomograms Registries Mass Screening National Cancer Institute (U.S.)Kaplan-Meier Estimate Confidence Intervals Clinical Trials as Topic Proportional Hazards Models ROC Curve Prevalence Regression Analysis Radiation Injuries Severity of Illness Index

Geographicals3

United States Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prostatic Neoplasms Prostate Prostate-Specific Antigen Receptors, Androgen Androgens Cell Line, Tumor Androgen Antagonists Prostatectomy Prostatic Hyperplasia Orchiectomy Gene Expression Regulation, Neoplastic Neoplasms, Hormone-Dependent Prostatic Intraepithelial Neoplasia Adenocarcinoma Tumor Markers, Biological Disease Progression Mice, Nude Early Detection of Cancer Neoplasm Metastasis Tosyl Compounds Bone Neoplasms Neoplasm Grading Transurethral Resection of Prostate Cell Proliferation Neoplasm Staging Neoplasm Invasiveness Tumor Cells, Cultured Risk Factors Apoptosis Androgen Receptor Antagonists Antineoplastic Agents, Hormonal Digital Rectal Examination Antineoplastic Agents Dihydrotestosterone Prognosis Genetic Predisposition to Disease Reverse Transcriptase Polymerase Chain Reaction Anilides Finasteride Neoplasm Proteins Xenograft Model Antitumor Assays Watchful Waiting Case-Control Studies RNA, Messenger Immunohistochemistry Neoplasm Transplantation Prospective Studies Follow-Up Studies Transplantation, Heterologous Treatment Outcome Metribolone Neoplasms Biopsy Blotting, Western Breast Neoplasms Flutamide Signal Transduction Retrospective Studies Prostatic Diseases Carcinoma Gene Expression Profiling Sensitivity and Specificity 5-alpha Reductase Inhibitors Prostatic Neoplasms, Castration-Resistant Risk Cell Growth Processes Biopsy, Needle Brachytherapy Risk Assessment Glutamate Carboxypeptidase II Neoplasm Recurrence, Local Time Factors United States Cohort Studies Anticarcinogenic Agents Down-Regulation RNA, Small Interfering Cell Division Prostatitis Questionnaires Genotype Incidence Survival Rate Lung Neoplasms Drug Resistance, Neoplasm Survival Analysis Taxoids PTEN Phosphohydrolase Mice, SCID Castration Cell Survival Odds Ratio Testosterone Testosterone Congeners Cancer Vaccines Azasteroids Ovarian Neoplasms Age Factors Predictive Value of Tests DNA, Neoplasm

No FAQ available that match "symptoms of prostate cancer prostate"